chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Wrong product administered
Clinical narrative: they had a patient who potentially received (they were not sure) a Moderna COVID-19 Vaccine Bivalent instead of a monovalent vaccine for the primary series; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (they had a patient who potentially received (they were not sure) a Moderna COVID-19 Vaccine Bivalent instead of a monovalent vaccine for the primary series) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     It was unknown patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. It was unknown patient had any relevant medical history or conditions, allergy, concomitant diseases and risk factor.     On an unknown date, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (they had a patient who potentially received (they were not sure) a Moderna COVID-19 Vaccine Bivalent instead of a monovalent vaccine for the primary series) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (they had a patient who potentially received (they were not sure) a Moderna COVID-19 Vaccine Bivalent instead of a monovalent vaccine for the primary series) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (they had a patient who potentially received (they were not sure) a Moderna COVID-19 Vaccine Bivalent instead of a monovalent vaccine for the primary series).    No concomitant medications was provided. No treatment medications was provided.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; HCP stated they accidentally administered 1 expired dose; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (HCP stated they accidentally administered 1 expired dose) and NO ADVERSE EVENT (No adverse event) in a 43-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 015B22A) for COVID-19 prophylaxis.     Patient did not have any known medical history/conditions, allergy, concomitant diseases and risk factors.     On 09-Mar-2023, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 09-Mar-2023,  after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (HCP stated they accidentally administered 1 expired dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (HCP stated they accidentally administered 1 expired dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (HCP stated they accidentally administered 1 expired dose).    No concomitant medications were reported. Patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine. No treatment medications were reported.
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: The vial was initially stored in refrigerator on 30-Jan-2023 (BUD 01-Mar-2023) and was adminitered on 02-Mar-2023; No adverse event; Patient had dose administered after 30-day Use By Date or after manufacturer date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient had dose administered after 30-day Use By Date or after manufacturer date), PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 30-Jan-2023 (BUD 01-Mar-2023) and was adminitered on 02-Mar-2023) and NO ADVERSE EVENT (No adverse event) in a 58-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 045H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 02-Mar-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 02-Mar-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient had dose administered after 30-day Use By Date or after manufacturer date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 30-Jan-2023 (BUD 01-Mar-2023) and was adminitered on 02-Mar-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient had dose administered after 30-day Use By Date or after manufacturer date), PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 30-Jan-2023 (BUD 01-Mar-2023) and was adminitered on 02-Mar-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient had dose administered after 30-day Use By Date or after manufacturer date) and PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 30-Jan-2023 (BUD 01-Mar-2023) and was adminitered on 02-Mar-2023).    No concomitant medications were reported. Dosage text was reported as unknown. It was reported that 5  bivalent vial of unknown size was administered to 5 patients after 30 days use by date. The vial never underwent any temperature excursions. No adverse reaction was reported by patient at that time.  No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-714731, US-MODERNATX, INC.-MOD-2023-714729 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-714731:Same reporter US-MODERNATX, INC.-MOD-2023-714729:Same reporter
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 immunisation, Interchange of vaccine products, No adverse event
Clinical narrative: 1st dose Moderna/2nd dose Pfizer; Revaccination with different COVID-19 vaccine; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (1st dose Moderna/2nd dose Pfizer), COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine) and NO ADVERSE EVENT (No adverse event) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002m21a) for COVID-19 prophylaxis.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (1st dose Moderna/2nd dose Pfizer), COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine) and NO ADVERSE EVENT (No adverse event). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (1st dose Moderna/2nd dose Pfizer), COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for INTERCHANGE OF VACCINE PRODUCTS (1st dose Moderna/2nd dose Pfizer) and COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine).    The concomitant medication was not reported by reporter. On 27-Sep-2021, patient received Pfizer Biontech Covid-19 Vaccine as a second dose, batch number FF8841 for an unknown indication. On 30-Sep-2022, patient received Pfizer Biontech Covid-19 Vaccine as a 4th dose Pfizer bivalent, batch number GJ5342 for an unknown indication. The treatment medication was not reported by reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-714740 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-714740:Bivalent Dose Case
Age: 85.0
Sex: M
Vaccine: COVID19-2
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: No adverse event; received the bivalent Moderna COVID19 vaccine after receiving another bivalent COVID19 vaccine in the past; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the bivalent Moderna COVID19 vaccine after receiving another bivalent COVID19 vaccine in the past) and NO ADVERSE EVENT (No adverse event) in an 85-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 010h22a) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (1st dose, lot #EN6201) on 11-Feb-2021, PFIZER BIONTECH COVID-19 VACCINE (2nd dose, lot #EN6203) on 04-Mar-2021, PFIZER BIONTECH COVID-19 VACCINE (3rd dose, lot #FF8841) on 27-Sep-2021, PFIZER BIONTECH COVID-19 VACCINE (5th dose Pfizer bivalent  and lot #GJ5342) on 30-Sep-2022; for COVID-19 prophylaxis: Moderna COVID-19 Vaccine (4th dose and lot #002m21a) on 14-Apr-2022. Past adverse reactions to the above products included No adverse event with Moderna COVID-19 Vaccine, PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.    On 08-Mar-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 08-Mar-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the bivalent Moderna COVID19 vaccine after receiving another bivalent COVID19 vaccine in the past). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the bivalent Moderna COVID19 vaccine after receiving another bivalent COVID19 vaccine in the past) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the bivalent Moderna COVID19 vaccine after receiving another bivalent COVID19 vaccine in the past).    No concomitant medications were reported. No treatment details were reported.
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; Patient was administered with 4 days expired bivalent vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered with 4 days expired bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in an adult female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7167B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 09-Mar-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 09-Mar-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered with 4 days expired bivalent vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered with 4 days expired bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient was administered with 4 days expired bivalent vaccine).    No concomitant medications were provided. It was reported that side effects were unknown. No treatment medication was provided.
Age: 40.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: They both had COVID Disease and a positive home COVID Test on 01FEB2023/On 01FEB2023 patient got COVID-19 with mild to moderate symptoms; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (They both had COVID Disease and a positive home COVID Test on 01FEB2023/On 01FEB2023 patient got COVID-19 with mild to moderate symptoms) in a 40-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Concurrent medical conditions included Anxiety and Migraine. Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) for Anxiety, FREMANEZUMAB (AJOVY [FREMANEZUMAB]) for Migraine.    On 07-Sep-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 01-Feb-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced COVID-19 (They both had COVID Disease and a positive home COVID Test on 01FEB2023/On 01FEB2023 patient got COVID-19 with mild to moderate symptoms). At the time of the report, COVID-19 (They both had COVID Disease and a positive home COVID Test on 01FEB2023/On 01FEB2023 patient got COVID-19 with mild to moderate symptoms) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Feb-2023, SARS-CoV-2 test: Positive.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Patient had not received any vaccine 4 weeks prior to COVID-19 vaccination.  Patient had received Monovalent Dose 1 on 09Mar2021 and dose 2 and dose 3 on an unknown date.  It was reported that the patient got COVID-19 with mild to moderate symptoms and this diseased was prolonged. With bivalent booster patient experienced no other symptoms.  Patient had not received any treatment.   This case was linked to US-MODERNATX, INC.-MOD-2023-714734 (E2B Linked Report). This case was linked to MOD-2023-714954 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-Mar-2023: Follow-up received, added additional reporter, updated patient initials, suspect drug details and I narrative.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-714734:Husband's case
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Wrong product administered
Clinical narrative: She received a Pfizer for her first dose but then was given a Modern bivalent for the second dose; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (She received a Pfizer for her first dose but then was given a Modern bivalent for the second dose) and NO ADVERSE EVENT (No adverse event) in an adult female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7173B) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (first dose). Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE.    On an unknown date, the patient received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (She received a Pfizer for her first dose but then was given a Modern bivalent for the second dose) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (She received a Pfizer for her first dose but then was given a Modern bivalent for the second dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (She received a Pfizer for her first dose but then was given a Modern bivalent for the second dose).    The concomitant medication was not reported by reporter. Patient received a Pfizer for her first dose but then was given a Modern bivalent for the second dose and Patient wanted to know where did they went from here with the vaccinations of the patient. The treatment medication was not reported by reporter.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No adverse event; Adult patient received a pediatric dose of the Moderna COVID19 vaccine monovalent as a first dose; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (Adult patient received a pediatric dose of the Moderna COVID19 vaccine monovalent as a first dose) and NO ADVERSE EVENT (No adverse event) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1414B) for COVID-19 prophylaxis.     It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On 09-Feb-2023, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 09-Feb-2023, the patient experienced WRONG PRODUCT ADMINISTERED (Adult patient received a pediatric dose of the Moderna COVID19 vaccine monovalent as a first dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Adult patient received a pediatric dose of the Moderna COVID19 vaccine monovalent as a first dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Adult patient received a pediatric dose of the Moderna COVID19 vaccine monovalent as a first dose).    Concomitant medication was not provided.   Treatment information was not provided.
Age: 19.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: No reported symptoms from patient or unknown at this time.
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: Anticoagulant therapy, Arrhythmia, Blood pressure increased, Heart rate increased
Clinical narrative: I developed an arrhythmia after the fifth dose. My pulse has run at times as high 180 BPM. My blood pressure also doubled. Before I got the fifth dose, my pulse was normally in the 60s and 70s. Before the fifth dose, my BP was in the neighborhood of 120/70. Since developing these symptoms, I have been prescribed CARDIZEM (120 mg three times a day), ELIQUIS (5 mg twice a day), flecainide (50 mg twice a day). Since taking the medications, I have been halfway stable.
Age: 31.0
Sex: M
Vaccine: COVID19-2
Symptoms: Loss of consciousness, Syncope
Clinical narrative: I had a random fainting event out of nowhere, I lost consciousness for about 20 seconds and came back to. I have an appointment in April for a follow up/ check up.
Age: 69.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: COVID-19, Cough, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: I had a dry cough, fever of 100, and sore throat. I tested positive for COVID-19 on the same day. I spoke to my doctor, and they prescribed me Paxlovid. I started feeling better on the evening of the 10th.
Age: 37.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chest X-ray normal, Cough, Herpes zoster, Pain, Upper respiratory tract infection
Clinical narrative: I had an upper respiratory infection so I developed a cough that hadn't cleared up in about a week. I was treated with steroids' previously, I didn't want that again so I went to urgent care, I was told it didn't seem like the same thing so I was given on February 13 some prescriptions. About a week later the shingles that developed started to get worse with pain, I was on an antiviral.
Age: 10.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient is 10 years, 11 months and was given Pfizer Bivalent 12 years and up dose of 0.3 ml left arm. No direct adverse event noted. Patient monitored 15 minutes Instructed may take Tylenol for body aches, fever, or chills if occurs. Instructed to seek emergency care if developed any chest pain, SOB, or swelling of mouth or tongue. Patient left clinic with mother in no acute distress.
Age: 31.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Aphasia, Blindness unilateral, Computerised tomogram head normal, Electrocardiogram, Hemiparesis
Clinical narrative: Stroke like symptoms 12/01/2022 losing sight /vision on one side, limb weakness on one side of body, difficulty with speak; aphasia. Went to ER. CT scan performed at the local medical center, cleared from stroke. Diagnosed with A-typical migraines, reoccurring symptoms on 12/09/2022, went back to ER, propranolol was prescribed started with 80mg than lowered to 60mg.
Age: 31.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Migraine, Muscular weakness, Neurological symptom, Therapy change
Clinical narrative: Stroke like symptoms 12/01/2022 losing sight /vision on one side, limb weakness on one side of body, difficulty with speak; aphasia. Went to ER. CT scan performed at the local medical center, cleared from stroke. Diagnosed with A-typical migraines, reoccurring symptoms on 12/09/2022, went back to ER, propranolol was prescribed started with 80mg than lowered to 60mg.
Age: 27.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Fatigue, Lethargy, Oropharyngeal pain
Clinical narrative: On January 30, 2023, my symptoms began with me feeling very lethargic. On that Tuesday January 31, 2023, I woke up with a sore throat. I was super tired, coughing, and had a fever. My cough was so severe that I had to start PAXLOVID. I was feeling better after taking that for five days of taking the medication. My cough lingered for a while.
Age: 27.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: On January 30, 2023, my symptoms began with me feeling very lethargic. On that Tuesday January 31, 2023, I woke up with a sore throat. I was super tired, coughing, and had a fever. My cough was so severe that I had to start PAXLOVID. I was feeling better after taking that for five days of taking the medication. My cough lingered for a while.
Age: 65.0
Sex: M
Vaccine: UNK
Symptoms: Underdose
Clinical narrative: Patient was given a dose of 0.2ml instead of the 0.3ml recommended. The vial did not contain 0.3ml doses.
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Asthma, COVID-19, Cough, Dyspnoea, Oropharyngeal pain
Clinical narrative: I had vaccination on 09/09/2022. I had symptoms on 01/20/2023 to include sore throat aching coughing. I tested COVID-19 positive on 01/23/2023. I was prescribed PAXLOVID. I did get rebound COVID-19. Nebulizer 4 times a day albuterol and regular asthma medications with SINGULAIR. I have not recovered and I am still dealing with a hard time breathing. My doctor calls it Post COVID-19 Asthma.
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain, SARS-CoV-2 test positive
Clinical narrative: I had vaccination on 09/09/2022. I had symptoms on 01/20/2023 to include sore throat aching coughing. I tested COVID-19 positive on 01/23/2023. I was prescribed PAXLOVID. I did get rebound COVID-19. Nebulizer 4 times a day albuterol and regular asthma medications with SINGULAIR. I have not recovered and I am still dealing with a hard time breathing. My doctor calls it Post COVID-19 Asthma.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Back pain, C-reactive protein increased, Dysstasia
Clinical narrative: I started with neck pain and upper back pain that developed overnight. Every morning, I felt like I had done manual labor the day before. Beginning at the end of August or beginning of September, I started noticing pain in both of my hips and glutes. By the end of September, the pain, stiffness, and weakness spread to the upper half of my thighs. It made it more difficult to rise from a seated position.  By early November, the muscle issues had spread to my shoulders and upper half of upper arms. It made it difficult to raise my arms. By December, I began having Tendonitis issues in my left elbow and my left thumb. In January, I began having Tendonitis issues in my right elbow. The Tendonitis issues prevent me from putting my hands behind my back. Beginning in February, I began having pain in my hands in the morning that eases up throughout the day. It feels more joint related that muscle related. Beginning in March, I began having an unusual sensation in my left knee and lower half of my quad. It felt like a swollen knee and tugging sensation in my quad when my knee was bent, but I did not experience pain. On March 11, I began feeling pain in that knee. All the muscle symptoms seem to get worse overnight and are at their worst first thing in the morning and after periods of inactivity. It has been treated with Celebrex with minimal improvement. I?ve taken Ibuprofen with minimal improvement. I?ve also taken Prednisone with a great amount of improvement while on a short high dose regiment and moderate to minimal improvement on extended lower doses.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Electromyogram normal, Magnetic resonance imaging head normal, Magnetic resonance imaging spinal normal, Mobility decreased, Muscle disorder
Clinical narrative: I started with neck pain and upper back pain that developed overnight. Every morning, I felt like I had done manual labor the day before. Beginning at the end of August or beginning of September, I started noticing pain in both of my hips and glutes. By the end of September, the pain, stiffness, and weakness spread to the upper half of my thighs. It made it more difficult to rise from a seated position.  By early November, the muscle issues had spread to my shoulders and upper half of upper arms. It made it difficult to raise my arms. By December, I began having Tendonitis issues in my left elbow and my left thumb. In January, I began having Tendonitis issues in my right elbow. The Tendonitis issues prevent me from putting my hands behind my back. Beginning in February, I began having pain in my hands in the morning that eases up throughout the day. It feels more joint related that muscle related. Beginning in March, I began having an unusual sensation in my left knee and lower half of my quad. It felt like a swollen knee and tugging sensation in my quad when my knee was bent, but I did not experience pain. On March 11, I began feeling pain in that knee. All the muscle symptoms seem to get worse overnight and are at their worst first thing in the morning and after periods of inactivity. It has been treated with Celebrex with minimal improvement. I?ve taken Ibuprofen with minimal improvement. I?ve also taken Prednisone with a great amount of improvement while on a short high dose regiment and moderate to minimal improvement on extended lower doses.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Myalgia, Neck pain
Clinical narrative: I started with neck pain and upper back pain that developed overnight. Every morning, I felt like I had done manual labor the day before. Beginning at the end of August or beginning of September, I started noticing pain in both of my hips and glutes. By the end of September, the pain, stiffness, and weakness spread to the upper half of my thighs. It made it more difficult to rise from a seated position.  By early November, the muscle issues had spread to my shoulders and upper half of upper arms. It made it difficult to raise my arms. By December, I began having Tendonitis issues in my left elbow and my left thumb. In January, I began having Tendonitis issues in my right elbow. The Tendonitis issues prevent me from putting my hands behind my back. Beginning in February, I began having pain in my hands in the morning that eases up throughout the day. It feels more joint related that muscle related. Beginning in March, I began having an unusual sensation in my left knee and lower half of my quad. It felt like a swollen knee and tugging sensation in my quad when my knee was bent, but I did not experience pain. On March 11, I began feeling pain in that knee. All the muscle symptoms seem to get worse overnight and are at their worst first thing in the morning and after periods of inactivity. It has been treated with Celebrex with minimal improvement. I?ve taken Ibuprofen with minimal improvement. I?ve also taken Prednisone with a great amount of improvement while on a short high dose regiment and moderate to minimal improvement on extended lower doses.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Red blood cell sedimentation rate increased, Sensory disturbance, Swelling, Tendonitis
Clinical narrative: I started with neck pain and upper back pain that developed overnight. Every morning, I felt like I had done manual labor the day before. Beginning at the end of August or beginning of September, I started noticing pain in both of my hips and glutes. By the end of September, the pain, stiffness, and weakness spread to the upper half of my thighs. It made it more difficult to rise from a seated position.  By early November, the muscle issues had spread to my shoulders and upper half of upper arms. It made it difficult to raise my arms. By December, I began having Tendonitis issues in my left elbow and my left thumb. In January, I began having Tendonitis issues in my right elbow. The Tendonitis issues prevent me from putting my hands behind my back. Beginning in February, I began having pain in my hands in the morning that eases up throughout the day. It feels more joint related that muscle related. Beginning in March, I began having an unusual sensation in my left knee and lower half of my quad. It felt like a swollen knee and tugging sensation in my quad when my knee was bent, but I did not experience pain. On March 11, I began feeling pain in that knee. All the muscle symptoms seem to get worse overnight and are at their worst first thing in the morning and after periods of inactivity. It has been treated with Celebrex with minimal improvement. I?ve taken Ibuprofen with minimal improvement. I?ve also taken Prednisone with a great amount of improvement while on a short high dose regiment and moderate to minimal improvement on extended lower doses.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Vitamin B12 increased
Clinical narrative: I started with neck pain and upper back pain that developed overnight. Every morning, I felt like I had done manual labor the day before. Beginning at the end of August or beginning of September, I started noticing pain in both of my hips and glutes. By the end of September, the pain, stiffness, and weakness spread to the upper half of my thighs. It made it more difficult to rise from a seated position.  By early November, the muscle issues had spread to my shoulders and upper half of upper arms. It made it difficult to raise my arms. By December, I began having Tendonitis issues in my left elbow and my left thumb. In January, I began having Tendonitis issues in my right elbow. The Tendonitis issues prevent me from putting my hands behind my back. Beginning in February, I began having pain in my hands in the morning that eases up throughout the day. It feels more joint related that muscle related. Beginning in March, I began having an unusual sensation in my left knee and lower half of my quad. It felt like a swollen knee and tugging sensation in my quad when my knee was bent, but I did not experience pain. On March 11, I began feeling pain in that knee. All the muscle symptoms seem to get worse overnight and are at their worst first thing in the morning and after periods of inactivity. It has been treated with Celebrex with minimal improvement. I?ve taken Ibuprofen with minimal improvement. I?ve also taken Prednisone with a great amount of improvement while on a short high dose regiment and moderate to minimal improvement on extended lower doses.
Age: 48.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Feeling abnormal, Nasopharyngitis, SARS-CoV-2 test positive
Clinical narrative: On December 23, 2022, I began to feel yucky, and it progressed through the night. The next morning, I had classic cold symptoms. I wasn't coughing but I felt different than a cold. I tested positive for COVID-19 on December 24, 2022. I went to urgent care at 4:00AM. They were not open, so I got a telehealth appointment. I had a home molecular test that tested positive as well and provided this for the urgent care. I was prescribed PAXLOVID and began taking it the same day. My symptoms were gone the next day. I tested positive for another 6 days. But then I got sick again with a rebound COVID-19 infection that lasted about 7 days with head cold symptoms.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, SARS-CoV-2 test positive
Clinical narrative: I tested positive for COVID - 19 on January 22,2023. I sent my husband to urgent care to see what I needed and I was told to come in and was prescribed fluxoid and Tamiflu, cough medicine and decongested. I still have a cough and not as befuddled as before but slow progression and getting my strength back with huffing and puffing.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood iron decreased, Blood test abnormal, Burning sensation, Dizziness
Clinical narrative: I had black spotting on both legs, and it is still not gone. It also itches and burns. I had low energy, dizziness, and tongue burning. I went to the doctor, and they gave me antibodies because they said it could be allergic reaction.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test normal, Pruritus, Skin discolouration, Tongue discomfort, Urine analysis normal
Clinical narrative: I had black spotting on both legs, and it is still not gone. It also itches and burns. I had low energy, dizziness, and tongue burning. I went to the doctor, and they gave me antibodies because they said it could be allergic reaction.
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Administered on 03/10/2023. The BUD for this vial was 02/18/2023.
Age: 63.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cardiac monitoring, Chest discomfort, Heart rate irregular, Stress
Clinical narrative: Got stressed out and felt like someone was sitting on my chest, began to have irregular heartbeats, wore heart monitor for 2 weeks.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Electrocardiogram normal, Eye movement disorder, Laboratory test normal
Clinical narrative: Within a few minutes of receiving the vaccine my daughter fainted. Her eyes rolled back into her head and she had seizure like tremors. After coming to she received water and crackers and then began vomiting. The following day she complained about chest pain and shortness of breath. She was taking to the emergency room where an EKG was preformed. EKG came back normal. Chest pains and shortness of breath continue for a week after the vaccine.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Seizure like phenomena, Syncope, Tremor, Vomiting
Clinical narrative: Within a few minutes of receiving the vaccine my daughter fainted. Her eyes rolled back into her head and she had seizure like tremors. After coming to she received water and crackers and then began vomiting. The following day she complained about chest pain and shortness of breath. She was taking to the emergency room where an EKG was preformed. EKG came back normal. Chest pains and shortness of breath continue for a week after the vaccine.
Age: 87.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ageusia, Anosmia, COVID-19, Nasopharyngitis, Pyrexia
Clinical narrative: In December 2022 I had cold-like symptoms but I had a fever of 102-103. I took a COVID-19 test and it was positive. The doctor called me and asked me to go to the doctor to check my kidney function so they would know which type of PAXLOVID to prescribe. I had runny nose and congestion only last for about five. I also lost my sense of taste and smell.  I still have not regained 100% of my sense of taste or smell.
Age: 87.0
Sex: F
Vaccine: COVID19-2
Symptoms: Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: In December 2022 I had cold-like symptoms but I had a fever of 102-103. I took a COVID-19 test and it was positive. The doctor called me and asked me to go to the doctor to check my kidney function so they would know which type of PAXLOVID to prescribe. I had runny nose and congestion only last for about five. I also lost my sense of taste and smell.  I still have not regained 100% of my sense of taste or smell.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Expired vaccine given, no AE reported
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Expired vaccine given, no AE reported
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram, Electroencephalogram, Epilepsy, Magnetic resonance imaging, Papillary thyroid cancer
Clinical narrative: October of 2021 I had a seizure... Spent the night in the ER, they did MRI CT EEG... Mentioned EEG may have had some abnormalities, but had nothing to compare it to. I had another seizure Feb 2022 10 minutes long... EEG in April 2022 showed no abnormalities... Still having seizures but now they are only 10-30 second absence seizures
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Petit mal epilepsy, Seizure, Thyroidectomy, Type 2 diabetes mellitus
Clinical narrative: October of 2021 I had a seizure... Spent the night in the ER, they did MRI CT EEG... Mentioned EEG may have had some abnormalities, but had nothing to compare it to. I had another seizure Feb 2022 10 minutes long... EEG in April 2022 showed no abnormalities... Still having seizures but now they are only 10-30 second absence seizures
Age: 30.0
Sex: M
Vaccine: COVID19-2, FLU4, HEP
Symptoms: Paraesthesia, Peripheral swelling, Pruritus, Skin discolouration, Urticaria
Clinical narrative: The day of my vaccine I developed a purple tingling in my toe on my right food next to my big toe, about 3 hours after administration of the vaccine. .  My toe then turned purple and swolen for two weeks.  My toe was almost fully healed by 2/22/2023.  On 2/22/2023, I noticed that I started to break out into non localized hives all over my body.. These hives will occur randomly and itch. If I start breaking out randomly, and I put lotion on my face ore use a towel I seem to break out.  Taking Zyrtec has helped with itching. I have also been put on steroids, Presidone for 6 days. My hives have started to get better with the combination of zyrtec and presisdone. They are still not gone though and it is 3/13/2023. I have been having non-localized outbreaks since 2/22/2023. They do seem to be getting better.  I am meeting with a dermatologist tomorrow.
Age: 52.0
Sex: F
Vaccine: VARCEL
Symptoms: Abdominal pain, Body temperature increased, Diarrhoea, Headache, Migraine
Clinical narrative: Severe abdominal pain, N/V/D, elevated temp >102°, full body hives,  mild seizures (x2), severe headache/migraines. Symptoms lasted overall approximately 2 weeks total with severity decreasing the last week.
Age: 52.0
Sex: F
Vaccine: VARCEL
Symptoms: Nausea, Seizure, Urticaria, Vomiting
Clinical narrative: Severe abdominal pain, N/V/D, elevated temp >102°, full body hives,  mild seizures (x2), severe headache/migraines. Symptoms lasted overall approximately 2 weeks total with severity decreasing the last week.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Condition aggravated, Dyskinesia, Gait disturbance, Hypersensitivity
Clinical narrative: 1-Allergic reaction, asthma attacks. Treatments were spariva, budesonide and formoterso fumarate inhallation aerosol, outcome was better after a few weeks 2- would wake up in the morning unable to control my hands, difficulty walking. It was like walking through tar. Left shoulder jerkiing out of control. no treatment. Doctors just watched it closely. Outcome is that eventually I got control of my hands and legs but should still jerks involuntarily although less sever than in the beginning. Since it's been over a year now, I'm guessing it permanent.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Neurological examination
Clinical narrative: 1-Allergic reaction, asthma attacks. Treatments were spariva, budesonide and formoterso fumarate inhallation aerosol, outcome was better after a few weeks 2- would wake up in the morning unable to control my hands, difficulty walking. It was like walking through tar. Left shoulder jerkiing out of control. no treatment. Doctors just watched it closely. Outcome is that eventually I got control of my hands and legs but should still jerks involuntarily although less sever than in the beginning. Since it's been over a year now, I'm guessing it permanent.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient received 3rd dose Pfizer-BioNTech COVID-19 monovalent instead of the Booster Pfizer-Bivalent vaccine in error.  No adverse effect noted.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Allergy to vaccine, Joint swelling, Pain, Pruritus, Rash
Clinical narrative: My mom get 2nd dose Shringrix vaccine at pharmacy, after a few hours later she developed generalized itchy urticarial rashes. 2 to 3 days later she noticed pain over the whole body and swelling of joints of hands. She did not have any reaction with the first dose. Then we went to urgent care. Doctor said she is allergetic to the vaccine.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Urticaria
Clinical narrative: My mom get 2nd dose Shringrix vaccine at pharmacy, after a few hours later she developed generalized itchy urticarial rashes. 2 to 3 days later she noticed pain over the whole body and swelling of joints of hands. She did not have any reaction with the first dose. Then we went to urgent care. Doctor said she is allergetic to the vaccine.
Age: 43.0
Sex: F
Vaccine: FLU4
Symptoms: Cough, Dyspnoea, Feeling of body temperature change, Headache, Influenza
Clinical narrative: MY EARS ARE RINGING, THROAT SWEALING,SHORTNESS OF BREATH,  COUGHING, RUNNING  NOSE, SEVERE HEADACHE,NAUSEA, FEELS HOT AND  COLD. TEARY EYES. THIS  TIME  I HAD FLU 4TIMES SINCE I RECEIVED FLU SHOT 10/2022,WENT  TO URGENT CARE. AND REPOETED TO MY  DOCTOR ALSO.  HAD  MY TONGUE  SWOLLEN HALF IN THE  PAST BUT  DIDN'T  WHAT WAS  THE  COURSE THEN.
Age: 43.0
Sex: F
Vaccine: FLU4
Symptoms: Laboratory test, Lacrimation increased, Nausea, Pharyngeal swelling, Rhinorrhoea
Clinical narrative: MY EARS ARE RINGING, THROAT SWEALING,SHORTNESS OF BREATH,  COUGHING, RUNNING  NOSE, SEVERE HEADACHE,NAUSEA, FEELS HOT AND  COLD. TEARY EYES. THIS  TIME  I HAD FLU 4TIMES SINCE I RECEIVED FLU SHOT 10/2022,WENT  TO URGENT CARE. AND REPOETED TO MY  DOCTOR ALSO.  HAD  MY TONGUE  SWOLLEN HALF IN THE  PAST BUT  DIDN'T  WHAT WAS  THE  COURSE THEN.
Age: 43.0
Sex: F
Vaccine: FLU4
Symptoms: Swollen tongue, Tinnitus
Clinical narrative: MY EARS ARE RINGING, THROAT SWEALING,SHORTNESS OF BREATH,  COUGHING, RUNNING  NOSE, SEVERE HEADACHE,NAUSEA, FEELS HOT AND  COLD. TEARY EYES. THIS  TIME  I HAD FLU 4TIMES SINCE I RECEIVED FLU SHOT 10/2022,WENT  TO URGENT CARE. AND REPOETED TO MY  DOCTOR ALSO.  HAD  MY TONGUE  SWOLLEN HALF IN THE  PAST BUT  DIDN'T  WHAT WAS  THE  COURSE THEN.
Age: 65.0
Sex: F
Vaccine: TDAP
Symptoms: Bursitis, Cartilage injury, Magnetic resonance imaging abnormal, Rotator cuff syndrome, Surgery
Clinical narrative: 1. Adverse Events resulting from injection: Bursitis, Torn Rotator Cuff injury, Torn Labrum, Shoulder impingement. These injuries required surgical intervention which took place on 9/22/2022. I am still recovering and have Physical Therapy 3x/week.
Age: 65.0
Sex: F
Vaccine: TDAP
Symptoms: X-ray limb
Clinical narrative: 1. Adverse Events resulting from injection: Bursitis, Torn Rotator Cuff injury, Torn Labrum, Shoulder impingement. These injuries required surgical intervention which took place on 9/22/2022. I am still recovering and have Physical Therapy 3x/week.
Age: 5.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient was given the incorrect Pfizer vaccine for dose 1. Patient was given Bivalent instead of the monovalent for dose 1. Patient recieved these on 11/18/22. The patients parents have been notified of the error by the office. Patient reported no concers.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient was 13 years and 10 months old.  Janssen only approved for 18 years and up. No adverse reactions noted.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Hot flush, Paraesthesia oral, Pharyngeal paraesthesia, Rash
Clinical narrative: Within 5 minutes tingling in lips & throat           15 minutes hot flashed in face           30-45 min rash on face, arms, chest, back               given Benadryl and EpiPen Some difficulty breathing that improved with EpiPen
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough case  dose 1 Pfizer  3/31/21  ER8733 dose 2 Pfizer  4/21/21  EW0158
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID vaccine breakthrough case
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19-2, FLUC4
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: So on 03-JAN-2023 early in the morning I noticed my breath was shallow and a sore throat and my rapid test came back positive immediately as the day progressed I got weak and had trouble walking I got headaches and had trouble hearing in my right ear I got Paxlovid prescribed and started taking immediately I had the metallic taste I had started to get better but was sick for two weeks and after two weeks I got better but about a week after I got sick again had to use my inhaler due to my asthma I had worse headaches and was extremely lethargic on the rebound and had to lay down for several days and was sick again for maybe ten days or so I still have shortness of breath and walking to fast will cause that as well, I was very lethargic and it is getting better little by little.